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Abstract
Purpose: To compare epithelium-removal and epithelium-disruption corneal
crosslinking (CXL) methods in Fourier analysis of keratometric data and clinical
outcomes.
Methods: In this double masked randomized clinical trial, each eye of 34 patients
with bilateral keratoconus was randomly allocated to either the epithelium-removal
or epithelium-disruption CXL treatment groups. Ocular examination, refraction,
uncorrected and best spectacle-corrected visual acuity (UCVA and BSCVA, respectively)
measurements, and Pentacam imaging (keratometry, pachymetry, and Fourier analysis)
were performed at baseline and at six-month follow-up period.
Results: Patients’ mean age was 23.3 ± 3.6 years. The preoperative thickness of the
thinnest point was 459.20 ± 37.40 µm and 455.80 ± 32.70 µm in the epithelium-removal
and epithelial-disruption CXL groups , respectively (P > 0.05). The corresponding figures
were 433.50 ± 33.50 µm and 451.90 ± 39.70 µm, respectively, six months after the
treatment (P = 0.0001). Irregularity component of the fourier analysis was 0.030 ± 0.016
µm in the epithelium-removal group and 0.028 ± 0.011 µm in the epithelium-disruption
group preoperatively (P > 0.05). This measurement was 0.031 ± 0.016 µm and 0.024
± 0.009 µm, respectively at month 6 (P = 0.04). The epithelium-disruption CXL group
had better results in terms of the thickness of the thinnest point and the irregularity
component as compared to the epithelium-removal group. The two study groups were
comparable in spherical equivalent, mean keratometry, UCVA, BSCVA, or other Fourier
analysis components (spherical R min, spherical eccentricity, central, peripheral regular
astigmatism, and maximum decentration) (P > 0.05).
Conclusion: This study shows that epithelium-disruption CXL is superior to epithelium-
removal CXL regarding the short-term changes in pachymetry and corneal irregularity.
Other evaluated parameters were comparable between the two techniques.
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INTRODUCTION
Keratoconus is a non-inflammatory bilateral
progressive corneal ectasia characterized by
corneal stromal thinning, protrusion, and irregular
astigmatism that results in light scattering. It
usually affects teenagers and young adults and
causes decreased visual acuity.[1] Keratoconus
has a mental and economic burden on patients
and drains the healthcare system budget.[2, 3] Its
prevalence was reported to be 1 in 2,000 patients
globally and 0.02% in the Tehran Eye Study.[1, 4]
Wollensak et al introduced corneal collagen
cross-linking (CXL)[5] to halt the progression of
keratoconus.[6, 7] Since then, CXL treatment has
been used widely in clinics across the world.
Its promising effects are also supported by a
meta-analysis study.[6] In the conventional CXL
method, the epithelium of the central cornea
(7–9 mm) is removed, and riboflavin solution is
applied. Then, ultra-violet A is used to enhance
crosslinking between adjacent corneal collagen
fibers.[5] Recently, some modifications were
made to reduce the manipulation of the corneal
epithelium, hence decreasing the initial pain,
visual discomfort, and stromal haziness.[8] One
suggested procedure is trans-epithelial CXL in
which hypo-osmolar riboflavin is applied to the
cornea through an intact epithelium. The efficacy
of this modification, however, was reported to
be less than that of the conventional method in
some studies.[9, 10] Therefore, partial epithelium-
removal CXL was developed, which uses vertical
and horizontal strips of de-epithelization using
a custom-designed surgical instrument (Daya
epithelium disruptor). The safety, efficacy, and
better tolerability of this method have been
reported in recent publications.[11–14]
Fourier analysis is a mathematical method
that can convert periodic continuous data
into unique expressions. Fourier analysis
transforms the extracted keratometric data
using a Pentacam Scheimpflug camera into
spherical R min, spherical eccentricity, maximum
decentration, central and peripheral astigmatism,
and irregularity components. Fourier analysis
can measure the 3-dimensional shape of the
cornea, producing specific numbers that provides
more comprehensive evaluation of cornea as
compared to mean keratometric values. The
repeatability and validity of Fourier analysis based
on data from a Pentacam device were shown in a
previous study by Sideroudi et al.[15] This analysis
provides a sensitive index for differentiating
corneal ectasia and can be used for the prompt
diagnosis of keratoconus.[16] It has been shown
that Fourier spherical and irregularity components
change over a year in progressive keratoconus,
but no significant changes occur in the other
two components.[17] The aim of this randomized
clinical trial (RCT) study was to evaluate the whole
shape of the cornea using Fourier analysis of
keratometric data obtained from a Pentacam®
HR (Oculus, Lynwood, WA, USA) and compare
the results between epithelium-removal versus




This was a double-masked RCT study that enrolled
34 bilateral keratoconus patients who had each
eye examined and operated on at Khalili Hospital.
Stratified randomization was performed for the
eyes and methods; for each patient, one eye
underwent epithelium-removal CXL and the other
eye underwent epithelium-disruption CXL in two
consecutive sessions with at least two weeks’
interval. The study protocol was in accordance
with the tenets of The Declaration of Helsinki and
was approved by the local ethics committee of
research at Shiraz University of Medical Sciences.
Written informed consent was obtained from
all participants. The RCT was registered at
Iranian Registry of Clinical Trials (Number #
IRCT2016112231028N1).
Patient Enrollment and Ocular Examination
The inclusion criteria were bilateral progressive
keratoconus diagnosed according to the
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Rabinowitz criteria for patients aged 18–25
years. The progression of the disease was defined
by an increase of at least 1 diopter (D) in mean
keratometry (K mean) or a reduction of at least
one line in the best-corrected visual acuity, within
the last 12 months. The exclusion criteria were
corneal thickness < 400 µm and K max > 61
D. In addition, pregnant and lactating women,
and patients with history of previous ocular
surgery, ocular herpetic infection, concurrent
keratitis, severe corneal opacity, or ocular surface
diseases such as dry eye, or autoimmune disease
were excluded. The demographic and clinical
characteristics of all patients were collected using
data forms. Data including refraction, uncorrected
and best spectacle-corrected visual acuity (UCVA
& BSCVA, respectively) expressed in the logarithm
of minimum angle of resolution scale (LogMAR),
and data obtained using a Pentacam® HR device
were compiled for all patients at baseline and six
months after the CXL procedures.
Fourier Analysis (corneal shape evaluation)
Fourier analysis transforms corneal keratometric
data obtained from the Pentacam device
into spherical components (spherical R min,
spherical eccentricity), regular astigmatism
(central astigmatism, peripheral astigmatism),
maximum decentration, and irregularity. The
spherical and regular astigmatism components
describe standard clinical parameters that can
be compensated by spectacles. Decentration
is a tilt of the corneal apex with respect to the
video-keratoscope axis, and irregularity refers to a
range of optical imperfections that degrade retinal
image quality.
Surgical Technique
In all cases, Glaupin 2%® (pilocarpine 2%, Sina
Darou, Tehran, Iran) eye drops were applied an
hour before the surgery to assure miosis during
the procedure and Anestocaine 0.5%® (tetracaine
0.5%, Sina Darou, Tehran, Iran) eye drops were
applied just before the surgery to provide topical
anesthesia. In the epithelium-removal group, 8.5
mm of corneal epithelium was removed completely
using a FUKASAKU Hockey Knife (Millennium
Surgical Corp, Pennsylvania, USA). A standard
preservative solution plus dextran-free riboflavin
0.1% (Sina Darou, Tehran, Iran) was applied at 3-
min intervals for 30 min. This step was followed
by corneal irradiation with UV-A at a wavelength
of 365 nm and power of 9 mW/cm2 at a short
distance from the eye (about 5 cm) for 10 min using
a CCL-365-vario (MLase AG, Germering, Germany).
Riboflavin was instilled every 3 min during corneal
irradiation. Finally, the eye was irrigated with 30
ml of balanced salt solution (BSS) and a bandage
contact lens (BCL) (CIBA Vision, Duluth, GA, USA)
was fitted over the cornea.
In the other eye, the corneal epithelium was
disrupted using a DAYA epithelium disruptor
(Duckworth & Kent Ltd, Hertfordshire, UK); the
rest of the procedure was performed the same
way as that described earlier. Ciprofloxacin 0.3%
eye drop was instilled every 6 hours for a week
and Betamethasone 0.1% eye drop was instilled
every 8 hours for a month in the operated eye,
postoperatively.
BCL was removed after corneal epithelial
defects completely healed. After removing the
BCL, patients were visited at weeks 1 and 3 to
assess whether there were any complications.
Final follow-up examination was performed six
months after the second procedure and included
slit-lamp biomicroscopy, refraction, UCVA, BSCVA,
and Pentacam® imaging.
Statistical Analysis
Categorical variables are expressed as frequency
(percentage) and continuous variables are
expressed as the mean value ± standard deviation
(SD). Normality of the data was evaluated using
the Kolmogorov–Smirnov test. A paired-samples
t-test or Wilcoxon test was used to compare
preoperative and postoperative data . The study
groups were compared using Student’s t-test or
the Mann–Whitney U-test. A P-value < 0.05 was
considered statistically significant.
RESULTS
A total of 68 eyes of 34 patients (10 men and 24
women) with bilateral keratoconus were included
in this RCT. The mean age of the participants
was 23.3 ± 3.6 years, ranging from 18 to 33
years. Each eye of the patients was randomly
assigned to either the epithelium-removal CXL
group (n = 34) or epithelium-disruption CXL group
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(n = 34). Except five patients who underwent CXL
procedure unilaterally, the CXL was performed
bilaterally in other subjects. Finally, the epithelium-
removal and the epithelium-disruption CXL groups
comprised 32 and 31 eyes, respectively. The
baseline demographic and clinical characteristics
and Fourier transform components were matched
between the two groups [Table 1].
Table 2 compares preoperative and
postoperative parameters between the two
groups. The mean number of days until BCL
removal in the conventional and epithelium-
disruption CXL groups were 4.5 ± 1.3 and 3.1
± 1.1 days, respectively (P < 0.0001). The two
treatment groups differed significantly with respect
to the postoperative thickness of the corneal
thinnest point (P = 0.0001) and the postoperative
irregularity component of the Fourier analysis (P
= 0.04). The epithelium-disruption CXL group had
less reduction in the pachymetry of the corneal
thinnest point and greater reduction in the Fourier
irregularity component in comparison to those
in the conventional CXL group. There was no
significant difference between the two treatment
groups with respect to the other clinical outcomes,
such as mean spherical equivalent, keratometry,
UCVA, BSCVA, and other components of the
Fourier analysis.
DISCUSSION
Corneal crosslinking is a procedure that has
changed the treatment pathway of keratoconus
patients. Before introducing this procedure, a fair
prognosis for a young patient diagnosed with
keratoconus was expected and the progressive
nature of the disease in many cases led to corneal
transplantation. However, despite the presence
of many patients with advanced keratoconus
requiring corneal transplantation, the future is
promising for keratoconus treatment.
The major CXL effect is to halt the progression
of keratoconus and improve the visual acuity and
keratometric data of many patients.[6, 7] During the
conventional CXL procedure, complete epithelium
debridement is performed, which has adverse
effects such as pain, increased risk of infection,
long healing time, and some stromal haziness.
Patients with advanced keratoconus do not
take advantage of conventional treatment methods
for visual acuity[18] and pachymetry.[5] Previous
studies evaluating the characteristics influencing
the outcomes of CXL for keratoconus revealed that
patients with a corrected distance visual acuity
(CDVA) of 20/40 or worse or amaximumK of 55.0 D
or more weremost likely to have improvement after
CXL.[18, 19] Corneal cross-linking in patients with
very mild keratoconus and visual acuity of 20/20 is
accompanied by the risk of stromal haziness and
reduced post-surgical visual acuity.[15] However,
in severe cases with low pachymetry (< 400
µm), it might hurt the endothelium and intraocular
structures.[5] Epithelial-disruption CXL is a modified
version of conventional CXL with reduced adverse
effects. In this modified procedure, some controlled
pores were induced on the epithelium surface
using a DAYA custom-designed instrument to
accelerate the diffusion of riboflavin molecules to
the stromal layer. In other words, partial removal
of the epithelium was implemented. This RCT
compared the six month results after epithelium-
removal CXL and epithelial-disruption CXL based
on the clinical characteristics and Fourier analysis
findings.
The results of the current study show that the
epithelial-disruption CXL method induces a less
reduction in corneal pachymetry in comparison to
that induced by conventional CXL after six months.
The difference between the mean pachymetry of
the thinnest point at baseline and after six-months’
follow-up in the epithelial-disruption group was
only 5 µm, while it was 25 µm in the epithelium
removal CXL group. We suggest this difference
is because of the different surgical methods.
Epithelial-disruption CXL is a less invasive method
in comparison to the conventional CXL and
little manipulation of the corneal epithelium is
performed through this procedure. This results
in a smaller reduction in the mean pachymetry
measurement and a corneal thickness closer to
the patients’ initial corneal thickness six months
after the surgery in the epithelial-disruption CXL
group. However, previous studies of epithelium
removal CXL revealed that after one year of
follow-up, postoperative pachymetry reaches
its initial measured value.[20] The mean number
of days until bandage removal following the
epithelium-disruption CXL method was 3.1 days,
while it was 4.5 days following the conventional
CXL method. After the epithelium-disruption
CXL procedure, the corneal ulcer was limited to
the many perforations of the epithelial surface,
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Table 1. Baseline characteristics of the epithelium removal and epithelial-disruption CXL groups.
Variables Epithelium-removal CXL
(n=32) Mean ± SD
Epithelial-disruption CXL
(n=31) Mean ± SD
P-value
Sex (m/f) (31.3% / 68.7%) (29% / 71%) 0.84
Age (years) 23.40 ± 3.80 23.20 ± 3.50 0.81
Sph equivalent (D) –2.70 ± 2.70 –3.90 ± 3.20 0.20
BSCVA (logMAR) 0.20 ± 0.20 0.19 ± 0.23 0.50
UCVA (logMAR) 0.55 ± 0.34 0.50 ± 0.37 0.69
Mean keratometry (D) 47.60 ± 3.10 48.20 ± 3.20 0.46
Thinnest point Pachymetry (µm) 459.20 ± 37.40 455.80 ± 32.70 0.70
Fourier analysis
Spherical R min 6.97 ± 0.56 6.8 ±0.64 0.56
Spherical ecc 0.79 ± 0.24 0.87 ± 0.21 0.33
Max decentration 0.78 ± 0.37 0.76 ± 0.35 0.95
Central astigmatism 0.31 ± 0.19 0.27 ± 0.12 0.75
Peripheral astigmatism 0.17 ± 0.11 0.18 ± 0.08 0.81
Irregularity 0.03 ± 0.016 0.028 ± 0.011 0.74
CXL, corneal crosslinking; BSCVA, best spectacle-corrected visual acuity; CXL, crosslinking; D, diopter; f, female; logMAR, log of
the minimal angle of resolution; m, male; Sph, spherical; UCVA, uncorrected visual acuity; µm, micrometer
while it was extended due to the completely
removed epithelium after the conventional CXL
method. Therefore, the number of days before
BCL removal was significantly reduced following
the epithelium-disruption CXL method. The
current results showed faster corneal stabilization
following the epithelial-disruption method in
comparison to the epithelium removal method.
Performing CXL in some advanced cases is risky
and may be limited because of a thin cornea.
Epithelial-disruption CXL would be a preferable
method in this scenario.
There was no difference in the refractive
components, UCVA, BSCVA, or mean keratometry
results between the two groups. Our findings
revealed that although epithelium removal CXL is
more aggressive, it does not lead to better short-
term follow-up results. We made a comparison
between our results and those of previous studies
that had compared epithelium removal CXL
with other CXL modifications [Table 3]. Hashemi
et al compared epithelium removal CXL with
partial trans-epithelial CXL (strips pattern de-
epithelization) after one year of follow-up.[13] They
found better corneal flattening with epithelium
removal CXL and less reduction in the central
pachymetry results in the partial trans-epithelial
CXL group. Their findings of better corneal
flattening was not consistent with our results, but
their central pachymetry finding was similar to
ours.
Our results from the Fourier analysis showed
a significant difference in corneal irregularity
between the two groups, with better results
achieved using the epithelial-disruption CXL
method. In other words, patients in the
epithelial-disruption group experienced a
greater reduction in corneal irregularities than
the epithelium removal CXL group after six
months. This might be due to the reduced level
of manipulation of the epithelium, which reveals
the advantage of the epithelial-disruption CXL
method over epithelium removal method. Ziaei
et al measured anterior corneal curvature variables
immediately after epithelial debridement during
the CXL procedure.[21] They found that the corneal
epithelium plays a role in masking the irregularity
of the underlying Bowman’s layer in keratoconic
eyes. Their results revealed that the magnitude
of anterior corneal keratometry, astigmatism, and
prolateness significantly increased immediately
after epithelial debridement during the CXL
procedure, strengthening our results with respect
to the preference of the epithelial-disruption
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Table 2. Clinical outcomes of epithelium removal CXL and epithelial-disruption CXL after a mean follow-up of six months
Variables Epithelium-off CXL
Mean ± SD
Daya epithelial disruption CXL
Mean ± SD
P-value
Spherical equivalent (D) Before –2.70 ± 2.70 –3.90 ± 3.20 0.31
After –3.00 ± 2.60 –3.70 ± 2.70
BSCVA (logMAR) Before 0.20 ± 0.20 0.19 ± 0.23 0.23
After 0.22 ± 0.22 0.17 ± 0.19
UCVA (logMAR) Before 0.55 ± 0.34 0.50 ± 0.37 0.79
After 0.47 ± 0.34 0.37 ± 0.31
Mean keratometry (D) Before 47.60 ± 3.10 48.20 ± 3.20 0.85
After 47.50 ± 3.30 48.20 ± 3.50
Thinnest point pachymetry (µm) Before 459.20 ± 37.4 455.80 ± 32.70 0.0001∗
After 433.50 ± 33.50 451.90 ± 39.70
Fourier analysis
Spherical R min Before 6.97 ± 0.56 6.80 ±0.64 0.99
After 6.90 ± 0.58 6.10 ± 0.66
Spherical ecc Before 0.79 ± 0.24 0.87 ± 0.21 0.29
After 0.84 ± 0.26 0.87 ± 0.21
Max decentration Before 0.78 ± 0.37 0.76 ± 0.35 0.92
After 0.77 ± 0.39 0.72 ± 0.36
Central astigmatism Before 0.31 ± 0.19 0.27 ± 0.12 0.85
After 0.30 ± 0.18 0.28 ± 0.12
Peripheral astigmatism Before 0.17 ± 0.11 0.18 ± 0.08 0.49
After 0.18 ± 0.09 0.18 ± 0.08
Irregularity Before 0.030 ± 0.016 0.028 ± 0.011 0.04∗
After 0.031 ± 0.016 0.024 ±0.009
BSCVA, best spectacle-corrected visual acuity; CXL, crosslinking; D, diopter; f, female; logMAR, log of the minimal angle of
resolution; m, male; UCVA, uncorrected visual acuity; µm, micrometer.
*Indicates for statistically significant P-values, (P < 0.05)
CXL method over the epithelium removal CXL
method because the former induces less corneal
irregularity after the CXL procedure. There was
no significant difference in spherical R min,
spherical eccentricity, maximum decentration, or
central and peripheral astigmatism between
the two groups. The results of the Fourier
components are compatible with the clinical
characteristics findings. There was no difference
in either spherical components or spherical
equivalent, as well as central astigmatism or
mean keratometry. The corneal irregularity
component cannot be measured in routine clinical
examination, although it is an indicator for distorted
image quality after spectacle compensation for
refractive error. To the best of our knowledge,
no previous studies have compared different CXL
methods using Fourier analysis. A comparison
between trans-epithelial CXL and epithelium
removal CXL in an RCT regarding higher order
aberrations via Zernike analysis was performed by
Godefrooij et al.[22] They hypothesized that more
improvement in BSCVA following trans-epithelial
CXL than following epithelium removal CXL was
related to greater advancement in the higher
order aberrations of the trans-epithelial group
relative to the epithelium removal group. Their
results did not show any significant difference
regarding higher order aberrations between the
two groups. The irregularity component of the
Fourier analysis might serve as a better answer for
that hypothesis.
The study design was a point of strength.
It was a double masked RCT where both the
patients and the optometrist who collected the
clinical data were blinded to the surgical methods.
Consequently, a favorable setting to compare
treatment effects without confounding factors was
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Table 3. Comparison of epithelium removal CXL with other CXL modifications
Reference
number.
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3–36 Epi-removal = 175
Control = 182


































































6 Epi-removal = 32
Partial = 31
BSCVA, best spectacle-corrected visual acuity; CT, central corneal thickness; CXL, crosslinking; D, diopter; epi, epithelium; F-U,
follow-up; logMAR, log of the minimal angle of resolution; m, month; mean k, mean keratometry; RCT, randomized clinical trial;
UCVA, uncorrected visual acuity; µm, micrometer; Δ = difference in change between two groups
provided. In addition, we selected our participants
from a pool of patients with bilateral keratoconus
and both treatment methods were performed in the
same patient. As a result, we examined two groups
with similar underlying healing factors. This study
addressed the short-term results; consequently,
other studies with more than one year of follow-up
are recommended to compare the efficacy of these
two methods in halting keratoconus progression in
the long-term.
In conclusion, the epithelial-disruption CXL
method produced better results with respect to
the thinnest point on pachymetry and corneal
irregularity than the epithelium removal CXL
method. There was no significant difference in
the improvement in spherical equivalent, mean
keratometry, UCVA, BSCVA, or overall shape of the
cornea according to Fourier components (except
irregularity) between the two CXL methods.
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